Insider Trading activities of Monopar Therapeutics (MNPR)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Monopar Therapeutics (MNPR) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Monopar Therapeutics since year 2005. Table 2 shows the detailed insider transactions of Monopar Therapeutics since 2005. The reporting company's ticker symbol is MNPR. The reporting company's CIK number is 1645469.
The total value of stock buying since 2005 is $6,005,104.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $55,317.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Monopar Therapeutics (MNPR).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-12 750,638 $6,005,104 0 $0 0 $0
2019-11 0 $0 0 $0 18,433 $55,317

Table 2. Detailed insider stock purchases, sales, and option exercises of Monopar Therapeutics insiders (MNPR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-12-18 Leo Karl Buy 156,563 8.00 1,252,504
2019-12-18 Hendricks Diane Buy 468,750 8.00 3,750,000
2019-12-18 Tsuchimoto Kim R (Chief Financial Officer) Buy 325 8.00 2,600
2019-12-18 Brown Michael J Buy 125,000 8.00 1,000,000
2019-11-26 Rioux Patrice Option Ex 18,433 3.00 55,317

Insider trading activities including stock purchases, stock sales, and option exercises of MNPR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Monopar Therapeutics (symbol MNPR, CIK number 1645469) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month